Risultati per: Linee-guida GOLD 2023,cosa cambia?

We sincerely thank the 646 peer reviewers who completed manuscript reviews for JAMA Internal Medicine in 2023.

We live in a tumultuous time of increased health care challenges within a milieu of ongoing COVID-19, climate change, war, gun violence, racial and ethnic discrimination, political divisions, and ongoing financial challenges to health care systems and financing. Amidst this background, the JAMA Internal Medicine editors came together to renew our commitment to publishing evidence to inform and improve health and health care. Our commitment is captured in our new mission statement: “To advance the equitable, person-centered, and evidence-based practice of internal medicine through publication of scientifically rigorous, innovative, and inclusive research, review, and commentary that informs dialogue and action with clinical, public health, and policy impact.”

JAMA Psychiatry saw a post–COVID-19 pandemic period of steady growth and impact in 2023. Our editorial team worked hard to maintain high standards, stay abreast of developments in the field, and present to our audience the best psychiatric research of the year. Among many others, we published a randomized clinical trial on sequential adaptive interventions for psychosis risk, an article on the adverse impact of abortion restrictions on mental health, and a Viewpoint series on mental health in a changing planet. We also continued to cover all aspects of the therapeutic potential and pitfalls of psychedelics and even devoted one of our popular podcasts to the topic.